Answers are grounded in this paper and cite their sources.
Psychedelic use shows no longevity advantage in prominent figures compared to cancer and aging researchers, suggesting further study is needed.
Psilocybin extends lifespan in aged mice, and this has prompted extensive media speculation about possible human longevity benefits. We examined mortality among prominent psychedelic personalities, researchers, and advocates who claimed psychedelic use (n = 11) and compared them with cancer (n = 12) and aging researchers (n = 5). All groups exceeded population life expectancy, reflecting the effect of socioeconomic advantage on lifespan, but psychedelic personalities did not outlive cancer and aging researchers. These findings highlight the need for rigorous mechanistic and epidemiological studies before inferring human anti-aging effects of psychedelics.
No takes yet. Share an insight, caveat, or question.
Leonard Lerer (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: